+ All Categories
Home > Documents > Rational Drug Design

Rational Drug Design

Date post: 09-Jan-2016
Category:
Upload: peers
View: 45 times
Download: 2 times
Share this document with a friend
Description:
Rational Drug Design. Using the 3D Shape of Proteins to Design Drugs that inhibit Protein Function. Download Cn3d software from NCBI. Why is protein structure important?. Each protein molecule has a characteristic 3D shape that results from coiling and folding of the polymer chain. - PowerPoint PPT Presentation
38
Rational Drug Design Using the 3D Shape of Proteins to Design Drugs that inhibit Protein Function Download Cn3d software from NCBI
Transcript
Page 1: Rational Drug Design

Rational Drug Design

Using the 3D Shape of Proteins to Design Drugs that

inhibit Protein Function

Download Cn3d software from NCBI

Page 2: Rational Drug Design

Why is protein structure important?

Each protein molecule has a characteristic 3D shape that results from coiling and folding of the polymer chain.

The function of a protein depends upon the shape of the molecule.

Page 3: Rational Drug Design

Protein chains

Each protein has a specific sequence of amino acids that are linked together, forming a polypeptide

Page 4: Rational Drug Design

The protein chain folds

Interactions between amino acids in the chain form:

– Alpha helices

– Beta sheets

– Random coils Together usually form the binding and active sites of proteins

Page 5: Rational Drug Design

And folds again..

• After folding, amino acids that were distant can become close

• Now the protein chain has a 3D shape that is required for it to function correctly

Page 6: Rational Drug Design

The final protein…3D structure

The final protein may be made up of more than one polypeptide chain.

The polypeptide chains may be the same type or different types.

Page 7: Rational Drug Design

Protein ChannelsRegulate movement of substances across the plasma membrane. E.g. The CFTR (cystic fibrosis transmembrane conductance regulator) protein pumps ions across membranes

Transport

Haemoglobin (far right) in red blood cells transports oxygen to cells around the body

Examples of Protein Function

HormonesInsulin binds to receptors on cell membranessignalling cells to take up glucose from the blood

Page 8: Rational Drug Design

Catalase - enzyme action

Add ferric ions (Fe 3+)

Rate increases 30 000-foldAdd Catalase

Rate increases 100 000 000-fold

Reactants Products

Hydrogen peroxide

oxygen

water

Location of active site where

Hydrogen peroxide binds

Hydrogen peroxide, a natural product of metabolism in your cells, is highly toxic in high concentrations and must be removed quickly!

Page 9: Rational Drug Design

How enzymes do it?

• Enzyme proteins have specific sites where all the action happens. We call this the active site. Molecules that need to be ripped apart or put together enter the active site.

• Each protein has a specific shape so it will only perform a specific job.

Ripping things apartJoining things together

Page 10: Rational Drug Design

Influenza Pandemics

The Hong Kong Flu in 1968 evolved into H3N2. 750,000 people died of the virus worldwide

The Spanish Flu in 1918, killed approximately 50 million people. It was caused by the H1N1 strain of

influenza A.

The Asian Flu in 1957 was the H2N2 influenza A strain. Worldwide it is

estimated that at least one million people died from this virus.

Page 11: Rational Drug Design

There are two types of protein = N and H.

N and H have special shapes to perform specific jobs for the virus.

Influenza viruses are named according to the proteins sticking out of their virus coat.

(H)

(N)

Designing a Flu Drug Step 1: looking for protein targets

Page 12: Rational Drug Design

Human Lung Cell

Virus Proteins on cell

surface

H attaches to cell surface proteins so virus can enter cell

Virus genes are released into the cell.

The lung cell is ‘tricked’ into using these genes to make new virus particles.

N cuts the links between the viruses and the cell surface so virus particles are free to go and infect more cells.

Page 13: Rational Drug Design

Blocking the active site

Neuraminidase in Cn3D

This link will open a Cn3D file of Neuraminidase with the drug relenza blocking

its active site

RELENZA

Australian team did it

Page 14: Rational Drug Design

Some facts…

• Calcium, sodium and potassium ions control essential functions inside cells: calcium, for example, helps regulate the contraction of muscle cells.

• Ion channels control the entry and exit of ions into and out of cells.

• Some conotoxins act as analgesics, interacting with ion channel receptors in nerves so the ion channel cannot open. Blocking ion channels stops ions from entering a neighbouring nerve fibre. No electrical impulse is set off so the ‘pain’ message is switched off!

Page 15: Rational Drug Design

The nerve impulse

++

++

- -

- -

Synaptic Junction

Sodium ion

Calcium ion

Acetylcholine

Ca2+Na+

4. Acetylcholine binds with receptor proteins changing 4. Acetylcholine binds with receptor proteins changing the shape of the ion channel. the shape of the ion channel. 5. This opens the sodium ion channel to let in sodium. 5. This opens the sodium ion channel to let in sodium. 6. Sodium ions set off an electrical impulse along the 6. Sodium ions set off an electrical impulse along the next nerve cell. next nerve cell. 7. The pain message is working. 7. The pain message is working.

To block pain we can try to target the ion channels.To block pain we can try to target the ion channels.

1. Electrical impulse generated along axon – sodium 1. Electrical impulse generated along axon – sodium ions (red) rush in and Potassium ions (green) rush outions (red) rush in and Potassium ions (green) rush out

2. Sodium ions accumulate causing Calcium ion channels to open.

3.3. Influx of Calcium Influx of Calcium causes acetylcholine to causes acetylcholine to be released into be released into synaptic junction.synaptic junction.

Page 16: Rational Drug Design

Na+ ion channel

Cell membrane (Phospholipid bylayer)

Inside neuronal cell

Outside neuronal cellYou will explore this part of the ion channel.

This is the section that binds acetylcholine &/or drug molecules causing the ion channel to change its shape.

Some conotoxins block acetylcholine (nACh) receptors that stud the surface of neurons.

Page 17: Rational Drug Design

Chemoinformatics

QSAR

Quantitative Structure Activity Relationship (QSAR) is a set of methods that tries to find a mathematical relationship between a set of descriptors of molecules and their activity.

The descriptors can be experimentally or computationally derived. Using regression analysis, one can extract a mathematical relationship between chemical descriptors and activity.

Page 18: Rational Drug Design

Descriptors in QSAR study

Constitutional Descriptors Topological Descriptors Geometrical Descriptors Electrostatic Descriptors Quantum Chemical Descriptors Thermodynamic Descriptors Reactivity Descriptors

Page 19: Rational Drug Design

Total number of atoms in the molecule Absolute and relative numbers of atoms of certain chemical

identity (C, H, O, N etc.) in the molecule Absolute and relative numbers of certain chemical groups

and functionalities in the molecule Absolute and relative numbers of single, double, triple,

aromatic or other bonds in the molecule Total and relative number of 6 membered aromatic rings Molecular weight and average atomic weight

Constitutional Descriptors

Page 20: Rational Drug Design

Molecular connectivity index Valence connectivity indices Shape indices Flexibility index Structural information content index Bonding information content index

Topological Descriptors

Page 21: Rational Drug Design

Molecular surface area Solvent-accessible molecular surface area Molecular volume Solvent-excluded molecular volume Principal moments of inertia of a molecule Shadow areas of a molecule Relative shadow areas of a molecule

Geometrical Descriptors

Page 22: Rational Drug Design

Electrostatic Descriptors

Atomic partial charges Minimum (most negative) and maximum (most positive)

atomic partial charges Polarity parameters Dipole moment Average ionization energy Minimum and maximum electrostatic potential at the

molecular surface Local polarity of molecule Total variance of the surface electrostatic potential Electrostatic balance parameter

Page 23: Rational Drug Design

Quantum Chemical Descriptors

Total energy of the molecule Standard heat of formation Electron-electron repulsion energy for a given atomic species Nuclear-electron attraction energy for a given atomic species Nuclear repulsion energy between two given atoms Total intramolecular electrostatic interaction energy Electron kinetic energy density

Page 24: Rational Drug Design

Ideally, chemicals with similar descriptors should show similar activity but similar in one context may not mean similar in another.

Difficult to represent interactions between descriptors

With many different types of descriptors, how do you compare them (e.g. what does it mean if the shapes are highly similar, but the charge distributions are very different?)

Problems with QSAR descriptors

Page 25: Rational Drug Design

PubChem Compoundhttp://pubchem.ncbi.nlm.nih.gov/

Page 26: Rational Drug Design

http://www.drugbank.ca/drugs/DB00558

Page 27: Rational Drug Design

http://www.drugbank.ca/drugs/DB00558

Page 28: Rational Drug Design
Page 29: Rational Drug Design

http://www.scfbio-iitd.res.in/bioinformatics/drugdesign.htm

Page 30: Rational Drug Design

Sanjeevini software has been developed to provide a computational pathway for automating lead design.

The user can upload a bimolecular (protein) target and a candidate drug.

The software identifies the potential active sites, docks and scores the candidate drug and returns four structures of the candidate drug bound to protein target together with binding free energies.

The Ligand and Protein should be provided in pdb format for all the modules.

Sanjeevini Software

Page 31: Rational Drug Design

NRDBSM database

Aimed specifically at virtual high throughput screening of small molecules and their further optimization into successful lead-like candidates.

It has been developed giving special consideration to physico-chemical properties and Lipinski's rule of five, which determines the solubility, permeability and transport characteristics across membranes.

Some of these are molecular weight, number of hydrogen bond donors and acceptors, and molar refractivity. Fixed precincts for these properties have been employed as filters to assemble the database.

Currently holds close to 17,000 molecules with simple structures, low molecular weight, less number of rings and rotatable bonds, low hydrophobicity such that after screening, optimization and consequent increase in molecular complexity, they would show a drift towards 'drug-like' property space.

Modules of Sanjeevini software

Page 32: Rational Drug Design

Weiner Index

The ability of protein to bind to its substrates and to inhibitors in a highly specific manner is an important feature of many biological processes.

For example, determination of binding free energy of the target (protein) with a ligand (any small molecule that binds protein) is a very important step to design new drugs, determination of toxicity of certain chemical materials on living organisms, and many other pharmaceutical and biochemical application developments.

The most crucial bottleneck to finding binding free energy of the target with a ligand is the computational time. For example, it requires more than a minute to find the binding free energy of a target (protein) with only a single ligand in rigid docking method.

For flexible (non-rigid) docking method, it may require several minutes for a single candidate only. There are millions of such ligands which need to be tested to determine the good candidate(s) for a particular target protein.

Page 33: Rational Drug Design

Lipinski Rule of Five

Lipinski rule of 5 helps in distinguishing between drug like and non drug like molecules. It predicts high probability of success or failure due to drug likeness for molecules complying with 2 or more of the following rules -

a) Molecular mass less than 500 Dalton b) High lipophilicity c) Less than 5 hydrogen bond donors d) Less than 10 hydrogen bond acceptors e) Molar refractivity should be between 40-130 - Molar refractivity is a measure of the total polarizability of a substance and is dependent on the temperature and the pressure.

These filters help in early preclinical development and could help avoid costly late-stage preclinical and clinical failures

Page 34: Rational Drug Design

Charge Derivation

Partial atomic charge is very crucial for computing physical, chemical and biological properties, and reactivity of molecules. Through the information of the atomic charge in a given species it is possible to predict the stability, solvation energetics of various molecules, and course of a particular reaction, determine its interaction with biological molecules and so on. The usefulness, notwithstanding, there is no direct method to determine the partial atomic charges from experiment. During the last few decades various methods have been developed to determine the partial atomic charges, but all these methods have their limitations. Two methods can be used for the partial charge derivation: TPACM4 or AM1BCC

Page 35: Rational Drug Design

TPACM4

Transferable Partial Atomic Charge Model – up to 4 bonds is used for deriving the partial atomic charges of small molecules for use in protein/DNA-ligand docking and scoring. The main idea of TPACM4 is based on a look up table of template fragments consisting of 4-bond paths around the atom being charged. This method overcomes the limitations of time complexity of assigning the partial atomic charges of a given molecule. The low value of average error against an experimentally observable physico-chemical properties indicates the reliability comparable to the RESP/AM1BCC results.

Page 36: Rational Drug Design

Active site finder:

The active site finder finds all the possible cavity points in a protein biomolecule along with the residues which are lining the cavity. The user can identify the cavity of interest on the basis of the amino acid lining the cavity and dock the candidate molecule in the cavity.

Page 37: Rational Drug Design

Software developed

1. SVMProt: Protein function prediction softwarehttp://jing.cz3.nus.edu.sg/cgi-bin/svmprot.cgi

2. INVDOCK: Drug target prediction software

3. MoViES: Molecular vibrations evaluation serverhttp://ang.cz3.nus.edu.sg/cgi-bin/prog/norm.pl

Page 38: Rational Drug Design

Bioinformatics database developed

1. Therapeutic target database http://xin.cz3.nus.edu.sg/group/cjttd/ttd.asp2. Drug adverse reaction target database http://xin.cz3.nus.edu.sg/group/drt/dart.asp3. Drug ADME associated protein database http://xin.cz3.nus.edu.sg/group/admeap/admeap.asp4. Kinetic data of biomolecular interactions database http://xin.cz3.nus.edu.sg/group/kdbi.asp5. Computed ligand binding energy database http://xin.cz3.nus.edu.sg/group/CLiBE/CLiBE.asp


Recommended